Clinical Trial Update: Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D [Phase 4]

View source ↗

Summary

This clinical trial update describes changes in the gastrointestinal microbiota of IBS patients treated with the probiotic VSL#3 in a Phase 4 study; the current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Irritable Bowel Syndrome Diarrhea Predominant

Drugs mentioned

• VSL#3

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: UNKNOWN